PainReform (PRFX) announced that it has received a notification from Nasdaq advising the company that it no longer satisfied the minimum $2.5M stockholders’ equity requirement for continued listing on Nasdaq set forth in Nasdaq Listing Rule 5550(b)(1) or, alternatively, the requirement that the company either maintain a market value of listed securities of at least $35M or generate net income from continuing operations of $500,000 in the most recently completed fiscal year or two of the last three most recently completed fiscal years.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter